These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6668546)

  • 1. Pharmacokinetic and pharmacodynamic modelling of trimazosin and its major metabolite.
    Meredith PA; Kelman AW; Elliott HL; Reid JL
    J Pharmacokinet Biopharm; 1983 Aug; 11(4):323-35. PubMed ID: 6668546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the pharmacokinetics and pharmacodynamics of trimazosin.
    Kelman AW; Meredith PA; Elliott HL; Reid JL
    Biopharm Drug Dispos; 1986; 7(4):373-88. PubMed ID: 3768492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of trimazosin in man.
    Reid JL; Meredith PA; Elliott HL
    Am Heart J; 1983 Nov; 106(5 Pt 2):1222-8. PubMed ID: 6637788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of pharmacokinetic-pharmacodynamic modelling for the comparison of quinazoline alpha-adrenoceptor agonists in normotensive volunteers.
    Meredith PA; Elliott HL; Kelman AW; Reid JL
    J Cardiovasc Pharmacol; 1985; 7(3):532-7. PubMed ID: 2410686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimazosin in normotensive subjects.
    Elliott HL; Vincent J; Hughes DM; Meredith PA; Reid JL
    Clin Pharmacol Ther; 1984 Feb; 35(2):156-60. PubMed ID: 6141018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in drug responses--a comparative study of trimazosin and alpha 1-adrenoceptor responses in normotensive Caucasians and West Africans.
    Vincent J; Elliott HL; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1986 Apr; 21(4):401-8. PubMed ID: 3011048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic modelling of the alpha adrenoceptor antagonist doxazosin.
    Meredith PA; Elliott HL; Kelman AW; Vincent J; Reid JL
    Xenobiotica; 1988 Jan; 18(1):123-9. PubMed ID: 2895548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimazosin: relationships between hypotensive effect, vascular responsiveness, and drug and metabolite concentrations.
    Vincent J; Elliott HL; Meredith PA; Reid JL
    J Cardiovasc Pharmacol; 1985; 7(5):913-8. PubMed ID: 2413300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular effects of trimazosin and prazosin in the rabbit.
    Vincent J; Hamilton CA; Reid JL
    Clin Exp Pharmacol Physiol; 1986 Aug; 13(8):593-608. PubMed ID: 2878751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cimetidine on the pharmacokinetics, pharmacodynamics and alpha 1-adrenoceptor responsiveness of trimazosin in man.
    Vincent J; Elliott HL; Meredith PA; Hughes DM; Reid JL
    Eur J Clin Pharmacol; 1985; 29(3):301-6. PubMed ID: 3000797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Age on the Pharmacokinetics and Pharmacodynamics of Cardiovascular Drugs: Application of Concentration-Effect Modeling. 3. Trimazosin.
    Meredith PA; Scott PJ; Kelman AW; Hughes DM; Reid JL
    Am J Ther; 1995 Aug; 2(8):541-545. PubMed ID: 11854824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a sustained-release trimazosin tablet formulation.
    Flouvat B; Fodor F; Roux A; Bianchine JR
    Am Heart J; 1983 Nov; 106(5 Pt 2):1228-34. PubMed ID: 6637789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension.
    Sampieri L; Cuspidi C; Boselli L; Angioni L; Castiglioni G; Zanchetti A; Mancia G
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):535-42. PubMed ID: 2908716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of trimazosin and methyldopa in hypertension.
    Aronow WS; Tobis J; Hughes D; Siegel J; Easthope J
    Clin Pharmacol Ther; 1977 Oct; 22(4):425-9. PubMed ID: 332438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of trimazosin and its effects on blood pressure, renal function and proteinuria during short-term therapy of patients with impaired renal function and hypertension.
    van Kalken CK; van der Meulen J; Oe PL; Vriesendorp R; Donker AJ
    Eur J Clin Pharmacol; 1986; 31(1):63-8. PubMed ID: 3780829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimazosin for the treatment of hypertensive patients failing to respond to thiazides.
    Oberman A; Pool PE
    Am Heart J; 1983 Nov; 106(5 Pt 2):1258-64. PubMed ID: 6356855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiovascular effects of trimazosin.
    Constantine JW; Hess HJ
    Eur J Pharmacol; 1981 Sep; 74(2-3):227-38. PubMed ID: 6120084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of trimazosin and prazosin on blood pressure and on pressor responses to phenylephrine in rats.
    Constantine JW; Lebel W; Weeks R
    Am Heart J; 1983 Nov; 106(5 Pt 2):1216-21. PubMed ID: 6637787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The determination of trimazosin and its metabolite CP23445 in whole blood by high performance liquid chromatography using fluorescence detection.
    Hughes MA; Meredith PA; Elliott HL
    J Pharmacol Methods; 1984 Aug; 12(1):29-34. PubMed ID: 6536811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.